CoChat

The DOI matches its Crossref record; 42 of the 44 references it cites were found in a registry or an index.

Expansion of CD4 T Lymphocytes Expressing Interleukin 17 and Tumor Necrosis Factor in Patients with Major Depressive Disorder

Open access
Alvarez-Mon, Miguel Angel, Gómez-Lahoz, Ana Maria, Orozco, Arancha, Lahera, Guillermo, Diaz, David, Ortega, Miguel A., Albillos, Agustin, Quintero, Javier, Aubá, Enrique, Monserrat, Jorge, Alvarez-Mon, Melchor · 2021 · Journal of Personalized Medicine

Abstract

Background: We have investigated the distribution of the Th1, Th2 and Th17 subsets in circulating CD4+ T lymphocytes and their naïve (TN), effector (TE), central (TCM) and effector memory (TEM) activation/differentiation stages in patients with major depressive disorder (MDD). Methods: Thirty MDD patients and 30 healthy controls were studied. The counts of circulating CD4+ T lymphocytes and their distribution on the TN, TE, TCM and TEM activation/differentiation stages were analyzed by polychromatic flow cytometry. The intracytoplasmic interferon gamma (IFNγ), interleukin (IL)-4, IL-17A and tumor necrosis factor alpha (TNF-alpha) and membrane CD28 expression were also measured. The serum IFNγ, IL-4, Il-17A and TNF-alpha were measured by Luminex, respectively. Results: MDD patients had normal counts of CD4+ T lymphocytes and of their TN, TCM and TEM subsets but increased number and percentage of TE CD4+ subset. CD4+ T lymphocytes had significantly enhanced percentage of cells that express IL-17 and TNF-alpha explained by the expansions found in the TN, TCM and, TEM and TCM, TEM and TE activation/differentiation stages, respectively. A selective increase in the percentages of TCM and TEM expressing IFNγ was also observed. We found a significant correlation between the percentages of CD4+ T lymphocytes expressing IFNγ and TNF-alpha in these patients. MDD patients showed increased serum levels of IL-17 and TNF-alpha, but normal IFNγ and IL-4 concentration. Limitations: the cross-sectional nature of the study could be considered a limitation. Conclusions: MDD patients have abnormal circulating CD4+ T lymphocytes with expansion of the IL-17 and TNF-alpha expressing cells as well as increased levels of circulating IL-17 and TNF-alpha.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/jpm11030220

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Dot plots represent the flow cytometry gating strategy and histograms of the intracellular interleukin (IL)-17A, interferon (IFN)γ, tumor necrosis factor alpha (TNF-alpha) and IL-4 expression by total circulating CD4+ T lymphocytes and TN, TCM, TEM and TE subsets in a representative case of MDD. The first row of dot plots represents the selected gates and percentages to obtain the total CD4+ T lymphocytes and TN, TCM, TEM and TE subsets in the presence of PMA (50 ng/mL) stimulation for 4 h. Histograms represent the percentages of IL-17A, IFNγ, TNF-alpha and IL-4 producing cells in the indicated CD4+ T lymphocytes subsets. Gating strategy: (A) Selection of lymphocytes by size (FSC) and complexity (SSC). (B) Exclusion of doublets. (C) Exclusion of dead cells. (D) Negative selection of CD4+ T lymphocytes using CD3+CD8- cells. (E) Expression of IFNγ and IL-17A in total CD4+ T lymphocytes. (F) Analysis of the activation/differentiation states of CD4+ T lymphocytes. (G–J) Expression of IFNγ and IL-17A in TN, TCM, TEM and TE lymphocytes.
Figure 1 Dot plots represent the flow cytometry gating strategy and histograms of the intracellular interleukin (IL)-17A, interferon (IFN)γ, tumor necrosis factor alpha (TNF-alpha) and IL-4 expression by total circulating CD4+ T lymphocytes and TN, TCM, TEM and TE subsets in a representative case of MDD. The first row of dot plots represents the selected gates and percentages to obtain the total CD4+ T lymphocytes and TN, TCM, TEM and TE subsets in the presence of PMA (50 ng/mL) stimulation for 4 h. Histograms represent the percentages of IL-17A, IFNγ, TNF-alpha and IL-4 producing cells in the indicated CD4+ T lymphocytes subsets. Gating strategy: (A) Selection of lymphocytes by size (FSC) and complexity (SSC). (B) Exclusion of doublets. (C) Exclusion of dead cells. (D) Negative selection of CD4+ T lymphocytes using CD3+CD8- cells. (E) Expression of IFNγ and IL-17A in total CD4+ T lymphocytes. (F) Analysis of the activation/differentiation states of CD4+ T lymphocytes. (G–J) Expression of IFNγ and IL-17A in TN, TCM, TEM and TE lymphocytes.CC BY · PubMed Central
Figure 2 Percentage of IL-17A, IFNγ, TNF-alpha and IL-4 expression by total circulating CD4+ T lymphocytes and TN, TCM, TEM and TE subsets in MDD patients and healthy controls after stimulation with PMA. Percentage of cells (y axis) that express the indicated cytokine by total CD4+ T lymphocytes and their TN, TCM, TEM and TE subsets (x axis) in MDD patients (black rectangles plots) and HCs (gray rectangles plots). * Significant difference between MDD and HCs for the indicated variable.
Figure 2 Percentage of IL-17A, IFNγ, TNF-alpha and IL-4 expression by total circulating CD4+ T lymphocytes and TN, TCM, TEM and TE subsets in MDD patients and healthy controls after stimulation with PMA. Percentage of cells (y axis) that express the indicated cytokine by total CD4+ T lymphocytes and their TN, TCM, TEM and TE subsets (x axis) in MDD patients (black rectangles plots) and HCs (gray rectangles plots). * Significant difference between MDD and HCs for the indicated variable.CC BY · PubMed Central
Figure 3 Circulating CD4+ T lymphocytes and TN, TCM, TEM and TE subsets that are able to express IL-17A, IFNγ, TNF-alpha, and IL-4 in MDD patients and HCs. Absolute number (cells/μL) (y axis that are able to express the indicated cytokine by total CD4+ T lymphocytes and their TN, TCM, TEM and TE subsets (x axis)) in MDD patients (black rectangles plots) and HCs (gray rectangles plots). * Significant difference between MDD and HCs for the indicated variable.
Figure 3 Circulating CD4+ T lymphocytes and TN, TCM, TEM and TE subsets that are able to express IL-17A, IFNγ, TNF-alpha, and IL-4 in MDD patients and HCs. Absolute number (cells/μL) (y axis that are able to express the indicated cytokine by total CD4+ T lymphocytes and their TN, TCM, TEM and TE subsets (x axis)) in MDD patients (black rectangles plots) and HCs (gray rectangles plots). * Significant difference between MDD and HCs for the indicated variable.CC BY · PubMed Central
Figure 4 Correlations between the percentages of IFNγ and TNF-alpha expression by CD4+ T lymphocytes in MDD patients. Pearson correlation coefficient between percentages of expression of IFNγ and TNF-alpha was 0.562 (p < 0.0001).
Figure 4 Correlations between the percentages of IFNγ and TNF-alpha expression by CD4+ T lymphocytes in MDD patients. Pearson correlation coefficient between percentages of expression of IFNγ and TNF-alpha was 0.562 (p < 0.0001).CC BY · PubMed Central
Figure 5 Circulating serum levels of IL-17A, IFNγ, TNF-alpha and IL-4 in MDD patients (black rectangles plots) and HCs (gray rectangles plots). Serum concentrations (pg/μL) (y axis) of IFNγ, IL-17A, IL-4 and TNF-alpha. * Significant difference between MDD and HCs for the indicated variable.
Figure 5 Circulating serum levels of IL-17A, IFNγ, TNF-alpha and IL-4 in MDD patients (black rectangles plots) and HCs (gray rectangles plots). Serum concentrations (pg/μL) (y axis) of IFNγ, IL-17A, IL-4 and TNF-alpha. * Significant difference between MDD and HCs for the indicated variable.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 44 references

Research works printed but not linked: 1

  1. Malhi, G.S., and Mann, J.J. (2018, November 24). Depression. Lancet, Available online: https://linkinghub.elsevier.com/retrieve/pii/S0140673618319482.

Cited by

See all 60

Metadata

Authors
Alvarez-Mon, M. A., Gómez-Lahoz, A. M., Orozco, A., Lahera, G., Diaz, D., Ortega, M. A., Albillos, A., Quintero, J., Aubá, E., Monserrat, J., & Alvarez-Mon, M.
Affiliations
  • Department of Psychiatry and Medical Psychology, University Clinic of Navarra, Avda. Pío XII, 36, 31008 Pamplona, Spain
  • Department of Medicine and Medical Specialities, University of Alcala, 28871 Alcala de Henares, Spain
  • Hospital Universitario Príncipe de Asturias (ES)
  • Universidad de Alcalá (ES)
  • Universidad Complutense de Madrid (ES)
  • Clinica Universidad de Navarra (ES)
Venue
Journal of Personalized Medicine
Publisher
MDPI AG
Published
2021-03-19
Volume
11
Issue
3
Pages
220
ISSN
2075-4426 (ISSN-L)
OpenAlex
W3136411448
Cited by
57
References
44
Citations by year
2026: 3 · 2025: 9 · 2024: 7 · 2023: 12 · 2022: 12 · 2021: 14
FWCI
3.74
Type
journal article
Language
en
Open access
Locations
  • Journal of Personalized Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • e_Buah (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Instituto de Salud Carlos III (PI18/01726))
  • Comunidad de Madrid (B2017/BMD-3804)
Topics
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Keywords
major depressive disorder, CD4+ T cells, Th17 cells, IL-17, TNF-α, interferon-gamma, Th1/Th2 balance, central memory T cells, effector memory T cells, naive T cells, effector T cells, CD28, cytokines

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Expansion of CD4 T Lymphocytes Expressing Interleukin 17 and Tumor Necrosis Factor in Patients with Major Depressive Disorder. https://app.cochat.ai/papers/10.3390/jpm11030220
The paper
Alvarez-Mon, M. A., Gómez-Lahoz, A. M., Orozco, A., Lahera, G., Diaz, D., Ortega, M. A., Albillos, A., Quintero, J., Aubá, E., Monserrat, J., & Alvarez-Mon, M. (2021). Expansion of CD4 T Lymphocytes Expressing Interleukin 17 and Tumor Necrosis Factor in Patients with Major Depressive Disorder. Journal of Personalized Medicine. https://doi.org/10.3390/jpm11030220

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.